This inventor holds 1 USPTO granted patent. Top assignee: Morgan Stanley Senior Funding, Inc.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Ruud Brakenhoff: Innovator in Cancer Treatment
Introduction
Ruud Brakenhoff is a notable inventor based in Amsterdam, Netherlands. He has made significant contributions to the field of cancer treatment through his innovative research and development.
Latest Patents
Ruud Brakenhoff holds a patent for a method of treating cancer by administering an antibody that binds to 5T4. This patent represents a crucial advancement in the fight against cancer, showcasing his commitment to improving patient outcomes.
Career Highlights
Currently, Ruud Brakenhoff is associated with Morgan Stanley Senior Funding, Inc. His work at this esteemed company allows him to leverage his expertise in developing groundbreaking medical solutions.
Collaborations
Ruud collaborates with talented professionals such as David Satijn and Esther CW Breij. Together, they contribute to innovative projects that aim to enhance cancer treatment methodologies.
Conclusion
Ruud Brakenhoff's work exemplifies the spirit of innovation in the medical field, particularly in cancer treatment. His contributions are paving the way for future advancements that could significantly impact patient care.